Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 4921-4926, December 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tannock, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tannock, I.

Response of Aerobic and Hypoxic Cells in a Solid Tumor to Adriamycin and Cyclophosphamide and Interaction of the Drugs with Radiation1

Ian Tannock

Departments of Medicine and Physics, The Princess Margaret Hospital and Ontario Cancer Institute, Toronto, Ontario M4X 1K9 Canada

I have assessed the relative sensitivity of aerobic and hypoxic cells to Adriamycin (ADR) and cyclophosphamide (CY) in the drug-sensitive murine 16/C tumor. The end point used was tumor response to subsequent radiation given under aerobic or acutely hypoxic conditions.

Delay in tumor growth following 15 gray radiation alone to ~0.4 g tumors was about 3 days longer after aerobic than after hypoxic radiation. Prior treatment with CY had little effect on this difference, implying little selectivity of CY for killing aerobic or hypoxic cells, and the effects of CY and radiation were additive.

Treatment with ADR abolished the difference in response to aerobic and hypoxic radiation given from 0.5 to 2 hr after the drug, suggesting that most of the cells which survived treatment with ADR were hypoxic. Difference in response to aerobic and hypoxic radiation at 6 to 24 hr after ADR was equal to or greater than that in non-drug-treated mice, implying rapid reoxygenation after ADR. Experiments on small, nonpalpable tumors with a low proportion of hypoxic cells showed that ADR was slightly more effective than against larger tumors and that some aerobic cells were spared by the drug when the hypoxic fraction was small. Misonidazole is known to be selectively toxic for hypoxic cells, and a high dose of misonidazole gave a small increase in antitumor effects of ADR without increased toxicity.

My results suggest that ADR (but not CY) may spare hypoxic cells in a solid tumor and are consistent with limited diffusion of ADR from tumor blood vessels.

1 Supported by a Research Grant from the National Cancer Institute of Canada.

Received 4/ 5/82. Accepted 8/17/82.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
L. A. Edwards, J. Woo, L. A. Huxham, M. Verreault, W. H. Dragowska, G. Chiu, A. Rajput, A. H. Kyle, J. Kalra, D. Yapp, et al.
Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of Integrin-linked kinase (ILK)
Mol. Cancer Ther., January 1, 2008; 7(1): 59 - 70.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Xu and I. J. Fidler
Acidic pH-induced Elevation in Interleukin 8 Expression by Human Ovarian Carcinoma Cells
Cancer Res., August 1, 2000; 60(16): 4610 - 4616.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
J. A. Raleigh, S.-C. Chou, D. P. Calkins-Adams, C. A. Ballenger, D. B. Novotny, and M. A. Varia
A Clinical Study of Hypoxia and Metallothionein Protein Expression in Squamous Cell Carcinomas
Clin. Cancer Res., March 1, 2000; 6(3): 855 - 862.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.